Related Experiment Video
Updated: Aug 2, 2025

Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
The COVID-19 Illness: Addressing the Current Treatment Limitations and Care Gaps with a Novel Alternative and
Abstract:
We are approaching the fourth year of the COVID-19 pandemic. Although great progress has been made in addressing the SARS-CoV-2 infection, there are significant treatment limitations and care gaps that need to be addressed in order to more effectively treat patients critically ill with COVID-19 and the large population of patients with post-COVID symptoms. We highlight the significance of the cytokine storm in the immunothrombotic process of COVID-19 illness. Finally, we present scientific evidence of the utility of a novel complementary therapeutic agent, the glutathione-cyclodextrin complex, that will likely address those limitations and close those gaps. If confirmed by rigorous clinical trials, the complex will have a significant impact on the treatment of the entire spectrum of COVID-19 illness and contribute to the control or resolution of the COVID-19 pandemic.
Related Concept Videos
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Cystic Fibrosis: Management
Sinus disease and chronic...
Microorganisms in Medicine and Therapeutics
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

